POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL G.M. Chertow,P. Vart,N. Jongs, R.D. Toto,J.L. Gorriz, F.F. Hou,J.J.V. McMurray,R. Correa-Rotter,P. Rossing, C.D. Sjöström, B.V. Stefánsson,A.M. Langkilde, D.C. Wheeler,H. Lambers HeerspinkKidney International Reports(2021)引用 2|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要